Work

[Efficacy of ruxolitinib and prognostic factors in patients with myelofibrosis stratified by age].

Year: 2025

Type: article

Abstract: Patients with myelofibrosis stratified by age exhibited heterogeneous clinical features and gene mutation profiles but similar efficacy of ruxolitinib treatment and occurrence of adverse events.

Source: Europe PMC (PubMed Central)

DOI: 10.3760/cma.j.cn121090-20250113-00025

Authors: X H Liu, Y Yu, F M Yan, Q Meng, X W Jiang, Q L Ji, Z Y Liu, Y Y Zheng, M R Zhou, S Ma, C Y Chen

Institutions: Shandong University, Qilu Hospital of Shandong University, Weihai Municipal Hospital

Language: Chinese

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4415243851

FWCI:

Cites:

Cited by:

Related to: 10